EBOS Group Limited (ASX: EBO) - ETF Exposure
- Current share price for EBO : $15.930
EBOS Group Limited (EBO) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is an Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a marketer and distributor of animal care brands. On 31 March 2025, the Group acquired a 100% equity interest in SVS Veterinary Supplies Ltd and PPD Ltd (SVS Group). Additionally, In December 2025, the Group entered into an agreement to obtain control over ABT Nevada LLC.
EBO General Information +
| ASX Code | EBO |
| Website | http://www.ebosgroup.com |
| Industry/Sector | Health Care Distributors |
| Market Cap ($M) | 3,297 |
| EBO Share Price | $15.930 |
| Day High | $16.020 |
| Day Low | $15.800 |
| Last Close | $15.930 |
| EBO Share Price Movement | - ( No change ) |
Prices as at 16:40, 21 Sep 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Already own an Australian ETF? You may already have meaningful exposure to EBO
As a significant Australian company by market capitalisation, EBO is held across 4 ETFs spanning strategies that include health care distributors exposure . Its weighting in those funds means performance can have an outsized influence - when EBO moves, funds like VAS that hold it can move with it.
For more concentrated exposure, ETFs such as VAS (Vanguard Australian Shares Index ETF) allocate about 0% to EBO , while the average exposure across all 4 ETFs that hold it is around 0.1% .
Top ETF holdings
- Vanguard Australian Shares Index ETF (VAS) ~ 0%
Last updated: ETF data and holdings as at 21 September 2026
Own EBO directly or through an ETF?
How does holding EBOS Group Limited (EBO) shares directly compare to ETFs that include it?
|
EBO Direct
|
VAS
ASX |
|
|---|---|---|
| Holdings | 1 company | 331 holdings |
| EBO Weight | 100% | 0% |
| Diversification | Single Stock | Broad |
| Annual Cost | Brokerage only | 0.07% p.a. |
| Approx. Yield | 5.7% | 2.97% |
| Star Ratings | - |  |
Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not EBO's direct yield. Annual cost uses each ETF's MER.
EBO Exposure on $10,000 investment
How a $10,000 investment in EBOS Group Limited (EBO) one week ago compares with ETFs that hold it.
| Security | Investment type | Current price | 7-day price movement | Dollar change | Value today |
|---|---|---|---|---|---|
| EBOS Group Limited (EBO) | Direct share | $15.930 | -2.27% | -$227 | $9,773 |
| Vanguard Australian Shares Index ETF (VAS) | Equity - Australia | $109.380 | -0.17% | -$17 | $9,983 |
Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.
EBOS Group Limited (EBO) ETFs
4 ETFs hold EBOS Group Limited (EBO).
| ETF | EBO Weight | MER | Yield |
|---|---|---|---|
| Vanguard Australian Shares Index ETF (VAS) | 0% | 0.07% | 2.97% |
EBOS Group Limited (EBO) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| HFResult | 43.95¢ | 96.59% | 27 Aug 2026 | 18 Sep 2026 | - | - | - |
| Result | 42.01¢ | 95.77% | 5 Mar 2026 | 27 Mar 2026 | - | - | - |
| HFResult | 48.59¢ | 95.77% | 4 Sep 2025 | 24 Sep 2025 | - | - | - |
See all dividends from EBOS Group Limited (EBO) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
EBOS Group Limited (EBO) price-sensitive announcements
EBO - Full Year Results Media Release
EBOS Group Limited reported its full-year results for the year ending 30 June 2026, demons
EBOS Group Limited (EBO)
19 Aug 2026 | 7:37 AM
19 Aug 2026 | 7:37 AM
EBO - NZX Distribution Notice
EBOS Group Limited announced a distribution notice for its ordinary shares with a ticker c
EBOS Group Limited (EBO)
19 Aug 2026 | 7:31 AM
19 Aug 2026 | 7:31 AM
EBO - NZX Results Announcement
EBOS Group Limited released their annual financial results for the year ending 30 June 202
EBOS Group Limited (EBO)
19 Aug 2026 | 7:30 AM
19 Aug 2026 | 7:30 AM
EBO - Investor Presentation
EBOS Group Limited reported its financial performance for FY26, showcasing an overall reve
EBOS Group Limited (EBO)
19 Aug 2026 | 7:30 AM
19 Aug 2026 | 7:30 AM
EBOS Group Limited (EBO) Recent ASX Announcements
EBO Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026F | $275.24 | $141.31 | 13.10% | 26.56 | 98.90 | 2.64% | 100.0% |
| 2025F | $243.39 | $124.95 | -15.80% | 30.04 | 87.50 | 2.33% | 100.0% |
| 2024A | $285.24 | $148.43 | 7.40% | 22.30 | 113.67 | 3.43% | 100.0% |
EBO Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | ||
| EBOS Group Limited (EBO) | $3,296M | -0.0935 | -0.0370 | 0.1393 | 14.1725 | 14.7176 | 12.9179 | 6.19% | 4.77% | 5.41% |
| Sigma Healthcare Limited (SIG) | $29,436M | 0.1384 | 0.1631 | 0.1389 | 39.2308 | 33.7302 | 29.6167 | 1.57% | 1.78% | 2.00% |
EBO Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.58 | 14.30 | 1.20 | 3.02 |
| Market | 0.61 | 15.80 | 1.65 | 1.26 |
| Sector | 0.67 | 19.90 | 1.74 | 2.50 |
EBO Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Mark Alan Bloom | Non-Executive Director | 16 Sep 2022 |
| Mr Stuart McLauchlan | Non-Executive Director | 1 Jul 2019 |
| Mr Matthew Peter Muscio | Non-Executive Director | 1 Jan 2025 |
| Dr Tracey Leigh Batten | Non-Executive Director | 1 Jul 2021 |
| Ms Julie Tay | Non-Executive Director | 15 May 2023 |
| Ms Coline McConville | Non-Executive Director | 1 Feb 2025 |
| Ms Elizabeth(Liz) Mary Coutts | Non-Executive Director, Non-Executive Chairman | 7 Nov 2013 |
EBOS Group Limited (EBO) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 27 Mar 2026 | MCLAUCHLAN, Stuart | Issued | Indirect Shares | 134 | $22.090 | $2,960.060 |
| 27 Mar 2026 | TAY, Julie | Issued | Direct Shares | 71 | $11.624 | $825.300 |
| 27 Mar 2026 | MCCONVILLE, Coline | Issued | Direct Shares | 22 | $22.090 | $485.980 |
See all changes in directors' interest & trades for EBOS Group Limited (EBO) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
EBO Management
| Name | Position |
|---|---|
| Grant Viney | CEO Animal Care |
| Kristine James | CEO Medical Technology |
| Nick Munroe | CEO Retail Pharmacy Brands |
| Brett Barons | CEO Symbion & Healthcare Distribution |
| Adam Hall | Chief Executive Officer |
| Alistair Gray | Chief Financial Officer |
| Mithran Naiker | Chief Information Officer |
| Jacinta McCarthy | Executive General Manager |
| Janelle Cain | General Counsel |
EBO Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in EBOS Group Limited (EBO). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 12,854,170 (6.33%) | Australian Super Pty Ltd |
| 11,100,783 (5.36%) | FirstCape Group Limited |
| 10,737,285 (5.24%) | Accident Compensation Corporation |
EBO Calendar of Events
| Date | Event |
|---|---|
| 18 August 2027 | Report (Annual) |
| 18 August 2027 | Report (Prelim) |
| 24 February 2027 | Report (Interim) |
| 21 October 2026 | AGM |
| 22 September 2026 | Issued Shares |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
